The Importance of Loco-Regional Tumor Burden and Surgery on Survival in Patients With De Novo Stage Iv Breast Cancer; Post-Hoc Analyses of Protocol Mf07-01

Özmen, VahitÖzbaş, SerdarKaranlık, HasanMüslümanoğlu, Mahmutİğci, AbdullahCantürk, Z.Sezgin, Efe2020-07-252020-07-2520170008-54721538-7445https://doi.org/10.1158/1538-7445.SABCS16-P6-16-01https://hdl.handle.net/11147/9434San Antonio Breast Cancer Symposium -- DEC 06-10, 2016 -- San Antonio, TXBackground: The MF07-01 trial is a multicenter phase III randomized controlled trial of treatment naive stage IV BC patients comparing loco-regional surgery (LRS) followed by appropriate systemic therapy (ST) versus ST alone. Aims: To evaluate the importance of loco-regional tumor burden and surgery on overall survival rate in patients with de novo stage IV breast cancer.eninfo:eu-repo/semantics/closedAccessThe Importance of Loco-Regional Tumor Burden and Surgery on Survival in Patients With De Novo Stage Iv Breast Cancer; Post-Hoc Analyses of Protocol Mf07-01Conference Object10.1158/1538-7445.SABCS16-P6-16-01